BioTuesdays

Category - Markets

Senseonics

BTIG ups Sensenonics to buy; PT to $1

BTIG upgraded Sensenonics Holdings (NYSE American:SENS) to “buy” from “neutral” with a price target of $1, citing a commercial collaboration with Ascensia Diabetes Care, a financing agreement with Ascensia’s parent, PHC...

HCW starts Lumos Pharma at buy; PT $33

H.C. Wainwright initiated coverage of Lumos Pharma (NASDAQ:LUMO) with a “buy” rating and $33 price target. The stock closed at $13.80 on Aug. 3. Analyst Edward White writes that the company’s LUM-201 drug candidate is...

Nkarta Therapeutics

Stifel starts Nkarta at buy; PT $41

Stifel launched coverage of Nkarta (NASDAQ:NKTX) with a “buy” rating and 12-month target price of $41. The stock closed at $26.58 on Aug. 3. Nkarta is focused on the discovery, development, and potential...

Geron

Stifel starts Geron at buy; PT $3

Stifel initiated coverage of Geron (NASDAQ:GERN) with a “buy” rating and $3 price target. The stock closed at $1.59 on July 31. Geron is focused on the development and potential commercialization of a single product...

Onconova Logo

Maxim ups Onconova Therapeutics PT to $3 from $1.25

Maxim Group raised its price target for Onconova Therapeutics (NASDAQ:ONTX) to $3 from $1.25 after the company announced that the required number of survival events for the pivotal Phase 3 INSPIRE study of IV rigosertib...

Sierra Oncology

HCW starts Sierra Oncology at buy; PT $20

H.C. Wainwright launched coverage of Sierra Oncology (NASDAQ:SRRA) with a “buy” rating and $20 price target. The stock closed at $12.46 on July 29. Sierra Oncology is in the midst of a Phase 3 MOMENTUM study with its...

Heat Biologics

Maxim ups Heat Biologics PT to $5 from $2

Maxim Group raised its price target for Heat Biologics (NASDAQ:HTBX) to $5 from $2, citing the potential of the company’s vaccine platform to produce long-lasting cellular immunity against COVID-19. The stock closed at...